EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

IMPDH2 suppression impedes cell proliferation by instigating cell cycle arrest and stimulates apoptosis in pediatric hepatoblastoma

Linman Li, Yichi Wu, Hong-Ting Huang, June-Kong Yong, Zicheng Lv, Yi Zhou, Xuelin Xiang, Jie Zhao, Zhifeng Xi, Hao Feng, Qiang Xia

Journal of Cancer Research and Clinical Oncology · 2024

DOI: 10.1007/s00432-024-05858-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cancer Research and Clinical Oncology, 2024. Verfasst von Linman Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Liver Surgery, Renji Hospital (Punan Branch), School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China. Hauptthemen laut MEDLINE: Hepatoblastoma, IMP Dehydrogenase, Liver Neoplasms, Cell Proliferation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Science and Technology Development Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatoblastoma (HB) is the most common pediatric liver tumor, presenting significant therapeutic challenges due to its high rates of recurrence and metastasis. While Inosine Monophosphate Dehydrogenase 2(IMPDH2) has been associated with cancer progression, its specific role and clinical implications in HB have not been fully elucidated.

Methods

This study utilized Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) and Tissue Microarray (TMA) for validation. Following this, IMPDH2 was suppressed, and a series of in vitro assays were conducted. Flow cytometry was employed to assess apoptosis and cell cycle arrest. Additionally, the study explored the synergistic therapeutic effects of mycophenolate mofetil (MMF) and doxorubicin (DOX) on HB cell lines.

Results

The study identified a marked overexpression of IMPDH2 in HB tissues, which was strongly correlated with reduced Overall Survival (OS) and Event-Free Survival (EFS). IMPDH2 upregulation was also found to be associated with key clinical-pathological features, including pre-chemotherapy alpha-fetoprotein (AFP) levels, presence of preoperative metastasis, and the pre-treatment extent of tumor (PRETEXT) staging system. Knockdown of IMPDH2 significantly inhibited HB cell proliferation and tumorigenicity, inducing cell cycle arrest at the G0/G1 phase. Notably, the combination of MMF, identified as a specific IMPDH2 inhibitor, with DOX, substantially enhanced the therapeutic response.

Conclusion

The overexpression of IMPDH2 was closely linked to adverse outcomes in HB patients and appeared to accelerate cell cycle progression. These findings suggest that IMPDH2 may serve as a valuable prognostic indicator and a potential therapeutic target for HB. Impact The present study unveiled a significant overexpression of inosine monophosphate dehydrogenase 2 (IMPDH2) in hepatoblastoma (HB) tissues, particularly in association with metastasis and recurrence of the disease. The pronounced upregulation of IMPDH2 was found to be intimately correlated with adverse outcomes in HB patients. This overexpression appears to accelerate the progression of the cell cycle, suggesting that IMPDH2 may serve as a promising candidate for both a prognostic marker and a therapeutic target in the context of HB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepatoblastomaIMP DehydrogenaseLiver NeoplasmsCell ProliferationApoptosisCell Cycle CheckpointsHumansFemaleMaleChild, PreschoolDoxorubicinChildMiceAnimalsCell Line, TumorInfantPrognosisMice, Nude

Stichwörter der Autor:innen

Cell cycleHepatoblastomaHepatocellular carcinomaIMPDH2ImmunotherapyLiver transplantationNeoadjuvant therapyPediatric cancerRecurrence-free survivalSurvival

Substanzen

IMP DehydrogenaseIMPDH2 protein, humanDoxorubicin

Autor:innen und Institutionen

  • Department of Liver Surgery, Renji Hospital (Punan Branch), School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.
  • Shanghai Engineering Research Centre of Transplantation and Immunology, Shanghai, 200127, China.
  • Clinical Research Unit, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.
  • Department of Liver Surgery, Renji Hospital (Punan Branch), School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China. surgeonfeng@live.com.
  • Clinical Research Unit, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China. surgeonfeng@live.com.
  • Shanghai Engineering Research Centre of Transplantation and Immunology, Shanghai, 200127, China. surgeonfeng@live.com.

Förderung

  • Shanghai Science and Technology Development Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Li, L., Wu, Y., Huang, H. T., Yong, J. K., Lv, Z., Zhou, Y., Xiang, X., Zhao, J., Xi, Z., Feng, H., & Xia, Q. (2024). IMPDH2 suppression impedes cell proliferation by instigating cell cycle arrest and stimulates apoptosis in pediatric hepatoblastoma. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-024-05858-4

Vancouver

Li L, Wu Y, Huang HT, Yong JK, Lv Z, Zhou Y, et al. IMPDH2 suppression impedes cell proliferation by instigating cell cycle arrest and stimulates apoptosis in pediatric hepatoblastoma. Journal of Cancer Research and Clinical Oncology. 2024. doi:10.1007/s00432-024-05858-4

BibTeX
@article{Li2024,
  author = {Li, Linman and Wu, Yichi and Huang, Hong-Ting and Yong, June-Kong and Lv, Zicheng and Zhou, Yi and Xiang, Xuelin and Zhao, Jie and Xi, Zhifeng and Feng, Hao and Xia, Qiang},
  title = {IMPDH2 suppression impedes cell proliferation by instigating cell cycle arrest and stimulates apoptosis in pediatric hepatoblastoma},
  journal = {Journal of Cancer Research and Clinical Oncology},
  year = {2024},
  doi = {10.1007/s00432-024-05858-4}
}
Kostenlos starten →